More on INMD
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $13.49 |
|
|||
| Open | $13.50 | ||||
| 52 Wk High | $14.13 | ||||
| 52 Wk Low | $7.40 | ||||
| Day High | $13.68 | ||||
| Day Low | $13.50 | ||||
| P/E | 31.79 | ||||
| EPS | $0.43 | ||||
| Volume | 305,784 | ||||
- After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
- Form 3 InMode Ltd. For: May 19 Filed by: Moshe Itzkovich
- Form 3 InMode Ltd. For: May 19 Filed by: Nass Shlomo
- Form 6-K InMode Ltd. For: May 20
- InMode names new chairman and CFO in leadership changes
- InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer
- InMode to Present at Upcoming Investor Conferences and Events
- InMode Ltd. (INMD) PT Lowered to $14 at Baird
- InMode Ltd. (INMD) PT Lowered to $19 at Barclays
- InMode Ltd. (INMD) Misses Q2 EPS by 5c ; Offers Guidance
Entities mentioned with INMD
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Needham & Company | View Related Stories »
- Definitive Agreement | View Related Stories »
- Stock Buyback | View Related Stories »
- Show More...
